Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Maximus, a global leader known for managing government programs, recently delivered robust financial results for its fiscal 2024 third quarter.</li><li>The company showed notable organic growth and revenue expansion across its diversified segments, with total revenue reaching $1.31 billion, marking a 10.6% year-over-year increase.</li><li>This growth was driven mainly by the U.S. Federal Services segment, which achieved a significant 17.0% revenue increase primarily through expanded clinical programs.</li></ul>

Maximus, a global leader known for managing government programs, recently delivered robust financial results for its fiscal 2024 third quarter.The company showed notable organic growth and revenue expansion across its diversified segments, with total revenue reaching $1.31 billion, marking a 10.6% year-over-year increase.This growth was driven mainly by the U.S. Federal Services segment, which achieved a significant 17.0% revenue increase primarily through expanded clinical programs.

Maximus Inc.: Initiation Of Coverage - Transition to Medicaid Enterprise Systems As A Critical Pivot & Other Major Drivers

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

Nasdaq-100 Stock Index / Technical Analysis

<ul>
<li>$SPX remains below 5783, the upper-end of important target/resistance area we've discussed for a month+ (5670-5783). 5670 was prior all-time high set in July, while 5783 is 2% above 5670.</li>
<li>It's hard to call it a "decisive" breakout if SPX isn't even 2% above its prior high.  In 2007, SPX made a top after climbing 1-2% above its prior high.</li>
<li>The 2007 topping analog has tracked the current market almost perfectly, with similar backdrops to today including new Fed cutting cycle, recession indicators going off, yield curve un-inverting, defensives outperforming</li>
</ul>


$SPX remains below 5783, the upper-end of important target/resistance area we've discussed for a month+ (5670-5783). 5670 was prior all-time high set in July, while 5783 is 2% above 5670.
It's hard to call it a "decisive" breakout if SPX isn't even 2% above its prior high.  In 2007, SPX made a top after climbing 1-2% above its prior high.
The 2007 topping analog has tracked the current market almost perfectly, with similar backdrops to today including new Fed cutting cycle, recession indicators going off, yield curve un-inverting, defensives outperforming


Still No Decisive Breakout as SPX Tests 5783 Resistance; Ideal Time to Shift to Defensives

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Event-Driven

<ul>
<li>The <a href="https://www.smartkarma.com/entities/apm-human-services-internation" target="_blank" data-smartkarma-citation="entities:34808:1" rel="noopener">APM Human Services (APM AU)</a> IE considers Madison Dearborn Partners (MDP)’s A$1.45 offer fair and reasonable as it is within the A$1.40 to A$1.74 valuation range. </li>
<li>The offer is conditional on FIRB, US HSR and shareholder approval. FIRB approval should be forthcoming as MDP is the second-largest shareholder.</li>
<li>While the offer remains underwhelming, rollover shareholders and quiet retail boards should ensure the vote passes. At last close and for the 10 October payment, the gross/annualised spread is 1.4%/10.1%.</li>
</ul>


The APM Human Services (APM AU) IE considers Madison Dearborn Partners (MDP)’s A$1.45 offer fair and reasonable as it is within the A$1.40 to A$1.74 valuation range. 
The offer is conditional on FIRB, US HSR and shareholder approval. FIRB approval should be forthcoming as MDP is the second-largest shareholder.
While the offer remains underwhelming, rollover shareholders and quiet retail boards should ensure the vote passes. At last close and for the 10 October payment, the gross/annualised spread is 1.4%/10.1%.


APM Human Services (APM AU): Scheme Vote on 18 September

As we write this, fears of a reprisal attack by Saudi Arabia are being priced into the markets. Oil is surging on the back of the largest ever supply disruption in history.  Investment managers are likely caught on the wrong side of the Energy Sector move and were very underweight as the Sector’s performance has, year-to-date, been nothing but an anchor on performance.  The Energy Sector has underperformed for well over a decade and the sector is at its lowest weighting in the S&amp;P 500 going back to 2005. We are taking this opportunity to upgrade the Energy Sector to a Market Weight from an Underweight as we believe retaliatory action is highly likely.The move to value is a trend that we see likely to continue. Small-caps have also done an about face vs large caps (Russell 2000 vs Russell 1000) after having broken to RS lows not seen since 2009. We believe this will result in a move that would likely take us back up to the top of the range assuming a recession is off the table. In this report, we lay out our complete U.S. equity strategy, and make detailed comments and recommendations on each of our 12 Sectors.

 As we write this, fears of a reprisal attack by Saudi Arabia are being priced into the markets. Oil is surging on the back of the largest ever supply disruption in history.  Investment managers are likely caught on the wrong side of the Energy Sector move and were very underweight as the Sector’s performance has, year-to-date, been nothing but an anchor on performance.  The Energy Sector has underperformed for well over a decade and the sector is at its lowest weighting in the S&amp;P 500 going back to 2005. We are taking this opportunity to upgrade the Energy Sector to a Market Weight from an Underweight as we believe retaliatory action is highly likely.The move to value is a trend that we see likely to continue. Small-caps have also done an about face vs large caps (Russell 2000 vs Russell 1000) after having broken to RS lows not seen since 2009. We believe this will result in a move that would likely take us back up to the top of the range assuming a recession is off the table. In this report, we lay out our complete U.S. equity strategy, and make detailed comments and recommendations on each of our 12 Sectors.

U.S. Equity Strategy: Value and Small-Caps Appear to Be on the Cusp of Major Bullish Moves

United States

MAXIMUS, Inc. provides program management and consulting services to state and local governments throughout the United States.  The Company's services are designed to make government operations more efficient and cost effective while improving the quality of the services provided to program beneficiaries.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Maximus Inc (MMS US)

Maximus Inc.: Initiation Of Coverage - Transition to Medicaid Enterprise Systems As A Critical Pivot & Other Major Drivers

Maximus, a global leader known for managing government programs, recently delivered robust financial results for its fiscal 2024 third...

Baptista Research

Still No Decisive Breakout as SPX Tests 5783 Resistance; Ideal Time to Shift to Defensives

Still No Decisive Breakout as $SPX Tests 5783 Resistance; On watch for SPX bull trap/failed breakout, confirmed only on a break below 5670. 2007...

Vermilion Research

APM Human Services (APM AU): Scheme Vote on 18 September

While the offer remains underwhelming, rollover shareholders and quiet retail boards should ensure the vote passes. At the last close, the gross...

Arun George

U.S. Equity Strategy: Value and Small-Caps Appear to Be on the Cusp of Major Bullish Moves

As we write this, fears of a reprisal attack by Saudi Arabia are being priced into the markets. Oil is surging on the back of the largest ever...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)